Junko Matsuoka

836 total citations
25 papers, 692 citations indexed

About

Junko Matsuoka is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Junko Matsuoka has authored 25 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Cancer Research. Recurrent topics in Junko Matsuoka's work include Cancer Cells and Metastasis (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and TGF-β signaling in diseases (3 papers). Junko Matsuoka is often cited by papers focused on Cancer Cells and Metastasis (8 papers), Cancer, Hypoxia, and Metabolism (4 papers) and TGF-β signaling in diseases (3 papers). Junko Matsuoka collaborates with scholars based in Japan and United States. Junko Matsuoka's co-authors include Kosei Hirakawa, Masakazu Yashiro, Y. Kato, Satoru Noda, Tsuyoshi Hasegawa, Shinichiro Kashiwagi, Yosuke Doi, Tetsuji Sawada, Naoshi Kubo and Masaichi Ohira and has published in prestigious journals such as PLoS ONE, Cancer Research and British Journal of Cancer.

In The Last Decade

Junko Matsuoka

23 papers receiving 681 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junko Matsuoka Japan 11 377 371 230 120 84 25 692
Madelon Paauwe Netherlands 13 456 1.2× 380 1.0× 261 1.1× 114 0.9× 62 0.7× 16 805
Yanhua Xuan China 18 539 1.4× 381 1.0× 221 1.0× 115 1.0× 80 1.0× 47 884
Francesca De Bacco Italy 10 391 1.0× 359 1.0× 217 0.9× 143 1.2× 50 0.6× 13 814
Sivan Elloul United States 9 511 1.4× 375 1.0× 151 0.7× 92 0.8× 51 0.6× 24 742
M Mueller Germany 7 495 1.3× 586 1.6× 161 0.7× 83 0.7× 81 1.0× 15 804
Osamu Shinto Japan 15 388 1.0× 326 0.9× 174 0.8× 130 1.1× 104 1.2× 24 661
Gvantsa Kharaishvili Czechia 18 404 1.1× 347 0.9× 221 1.0× 153 1.3× 46 0.5× 26 776
Martin Boettcher Germany 5 466 1.2× 428 1.2× 314 1.4× 109 0.9× 52 0.6× 6 793
Angela M. Krebs Germany 3 478 1.3× 446 1.2× 321 1.4× 89 0.7× 50 0.6× 4 769
Swati Jalgaonkar United States 5 490 1.3× 458 1.2× 236 1.0× 82 0.7× 39 0.5× 7 782

Countries citing papers authored by Junko Matsuoka

Since Specialization
Citations

This map shows the geographic impact of Junko Matsuoka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junko Matsuoka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junko Matsuoka more than expected).

Fields of papers citing papers by Junko Matsuoka

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junko Matsuoka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junko Matsuoka. The network helps show where Junko Matsuoka may publish in the future.

Co-authorship network of co-authors of Junko Matsuoka

This figure shows the co-authorship network connecting the top 25 collaborators of Junko Matsuoka. A scholar is included among the top collaborators of Junko Matsuoka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junko Matsuoka. Junko Matsuoka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kitahata, Shogo, Yuka Kimura, Ayaka Nakamura, et al.. (2025). Mirikizumab Efficacy in Ulcerative Colitis: Association With Pretreatment Geboes Score Features in a Case Series. Inflammatory Bowel Diseases. 32(3). 581–583.
2.
Hori, Megumi & Junko Matsuoka. (2019). Kidney cancer incidence rates in the world from the Cancer Incidence in Five Continents XI. Japanese Journal of Clinical Oncology. 49(3). 295–296. 1 indexed citations
3.
Saito, Eiko & Junko Matsuoka. (2019). International comparison of Hodgkin and non-Hodgkin lymphoma incidence. Japanese Journal of Clinical Oncology. 50(1). 96–97. 6 indexed citations
4.
Fujii, Yuko, Makoto Nishimura, Junko Matsuoka, et al.. (2016). Feasibility and safety of EUS-FNA for mediastinal lesions. Progress of Digestive Endoscopy. 89(1). 74–75.
5.
Minoda, Yosuke, et al.. (2015). [Synchronous gastrointestinal stromal tumors of the rectum and duodenum: a case report].. PubMed. 112(11). 1991–7. 1 indexed citations
6.
Matsuoka, Junko, Masakazu Yashiro, Yosuke Doi, et al.. (2013). Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling. PLoS ONE. 8(5). e62310–e62310. 85 indexed citations
7.
Nakata, Bunzo, Ryosuke Amano, Junko Matsuoka, et al.. (2012). Spontaneously complete regression of pseudolymphoma of the remnant pancreas after pancreaticoduodenectomy. Pancreatology. 12(3). 215–218. 7 indexed citations
8.
Yashiro, Masakazu, Satoru Noda, Junko Matsuoka, et al.. (2012). Cancer‐associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells. Cancer Science. 103(4). 797–805. 56 indexed citations
9.
Yashiro, Masakazu, Satoru Noda, Shinichiro Kashiwagi, et al.. (2011). Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells. British Journal of Cancer. 105(7). 996–1001. 90 indexed citations
10.
Kashiwagi, Shinichiro, Tsutomu Takashima, Yuka Asano, et al.. (2011). [Lumpectomy and sentinel lymph node navigation surgery for breast cancer under local anesthesia].. PubMed. 38(12). 2017–9. 3 indexed citations
11.
Kato, Y., Masakazu Yashiro, Shinichiro Kashiwagi, et al.. (2011). Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells.. PubMed. 31(10). 3369–75. 37 indexed citations
12.
Kato, Y., Masakazu Yashiro, Satoru Noda, et al.. (2010). Expression of a Hypoxia-Associated Protein, Carbonic Anhydrase-9, Correlates with Malignant Phenotypes of Gastric Carcinoma. Digestion. 82(4). 246–251. 16 indexed citations
13.
Matsuoka, Junko, Masakazu Yashiro, Katsunobu Sakurai, et al.. (2010). Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma. Journal of Surgical Research. 174(1). 130–135. 131 indexed citations
14.
Yashiro, Masakazu, Satoru Noda, Shinichiro Kashiwagi, et al.. (2010). Myofibroblasts are associated with the progression of scirrhous gastric carcinoma. Experimental and Therapeutic Medicine. 1(4). 547–551. 20 indexed citations
15.
Kato, Y., Masakazu Yashiro, Satoru Noda, et al.. (2010). Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma. British Journal of Cancer. 102(5). 898–907. 55 indexed citations
16.
Doi, Yosuke, Masakazu Yashiro, Nobuya Yamada, et al.. (2010). Abstract 5206: VEGF-A/VEGFR-2 signaling might be a promising target for the tumor invasion of pancreatic cancer. Cancer Research. 70(8_Supplement). 5206–5206. 1 indexed citations
17.
Matsuoka, Junko, et al.. (1995). Chopstick retention suture for the closure of abdominal wounds.. PubMed. 181(5). 471–4. 3 indexed citations
18.
Matsuoka, Junko, et al.. (1994). A safe, easy technique for transduodenal sphincteroplasty.. PubMed. 179(4). 474–6. 1 indexed citations
19.
Pressler, Virginia, et al.. (1994). Stereotactic fine needle aspiration of mammographic lesions.. PubMed. 178(1). 54–8. 5 indexed citations
20.
Oda, Hideaki, Junko Matsuoka, Kenji Tadokoro, et al.. (1991). Detection of Burst‐promoting Activity in Spleens of Myeloproliferative Sarcoma Virus‐infected Mice Using Serum‐free Cultures. Acta Pathologica Japonica. 41(4). 259–264. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026